Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer.
Cieślikowski WA, Milecki P, Świerczewska M, Ida A, Kasperczak M, Jankowiak A, Nowicki M, Pantel K, Alix-Panabières C, Zabel M, Antczak A, Budna-Tukan J.
Cieślikowski WA, et al.
J Pers Med. 2023 Mar 30;13(4):608. doi: 10.3390/jpm13040608.
J Pers Med. 2023.
PMID: 37108995
Free PMC article.